CoChat

Direct-to-consumer genomics on the scales of autonomy

Open access
Vayena, Effy · 2015 · Journal of Medical Ethics

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Direct-to-consumer (DTC) genetic services have generated enormous controversy from their first emergence. A dramatic recent manifestation of this is the Food and Drug Administration's (FDA) cease and desist order against 23andMe, the leading provider in the market. Critics have argued for the restrictive regulation of such services, and even their prohibition, on the grounds of the harm they pose to consumers. Their advocates, by contrast, defend them as a means of enhancing the autonomy of those same consumers. Autonomy emerges as a key battle-field in this debate, because many of the ‘harm’ arguments can be interpreted as identifying threats to autonomy. This paper assesses whether DTC genomic services are a threat to, or instead, an enhancement of, personal autonomy. It deploys Joseph Raz's account of personal autonomy, with its emphasis on choice from a range of valuable options. It then seeks to counter claims that DTC genomics threatens autonomy because it involves manipulation in contravention of consumers’ independence or because it does not generate valuable options which can be meaningfully engaged with by consumers. It is stressed that the value of the options generated by DTC genomics should not be judged exclusively from the perspective of medical actionability, but should take into consideration plural utilities. Finally, the paper ends by broaching policy recommendations, suggesting that there is a strong autonomy-based argument for permitting DTC genomic services, and that the key question is the nature of the regulatory conditions under which they should be permitted. The discussion of autonomy in this paper helps illuminate some of these conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/medethics-2014-102026

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 62

Metadata

Authors
Vayena, E.
Affiliations
University of Zurich (CH)
Corresponding author
Vayena, Effy
Venue
Journal of Medical Ethics
Publisher
BMJ
Published
2014-05-05
Volume
41
Issue
4
Pages
310-314
ISSN
  • 0306-6800 (ISSN-L)
  • 1473-4257
OpenAlex
W2102719677
Cited by
62
References
43
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 10 · 2015: 4 · 2014: 5
FWCI
8.59
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Journal of Medical Ethics (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
  • Social Sciences › Law › Medical and Health Sciences Research
Keywords
direct-to-consumer genetic testing, individual autonomy, Joseph Raz, manipulation, consumer autonomy, 23andMe, genetic privacy, regulatory policy
MeSH terms
Commerce, Community Participation, Genetic Counseling, Genetic Testing, Humans, Public Policy, United States, United States Food and Drug Administration, Genomics, Personal Autonomy, Marketing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct-to-consumer genomics on the scales of autonomy. https://app.cochat.ai/papers/10.1136/medethics-2014-102026
The paper
Vayena, E. (2015). Direct-to-consumer genomics on the scales of autonomy. Journal of Medical Ethics. https://doi.org/10.1136/medethics-2014-102026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.